H6PD (hexose-6-phosphate dehydrogenase) is a bifunctional enzyme localized in the endoplasmic reticulum lumen that catalyzes the first two steps of the oxidative pentose phosphate pathway 1. The enzyme possesses both hexose-6-phosphate dehydrogenase and 6-phosphogluconolactonase activities 2, generating NADPH to maintain reducing cofactors in the oxidizing ER environment 3. H6PD's primary physiological role is supporting 11β-HSD1 reductase activity by providing essential NADPH, thereby indirectly regulating cortisol biosynthesis in tissues including fetal membranes 1. Mutations in H6PD impair 11-HSD1 oxo-reductase activity and are associated with apparent cortisone reductase deficiency 3. Beyond steroid metabolism, H6PD polymorphisms (R453Q and D151A variants) associate with polycystic ovary syndrome (PCOS) and obesity, potentially influencing insulin resistance and hyperandrogenism 45. Recent multiomics studies identify H6PD as a genetic risk factor for intracranial aneurysms 6, congenital vertebral malformations during spine development 7, and as a key regulator of tumor metabolism in mesothelioma through mannose and glutamate metabolite ratios 8. These findings indicate H6PD's importance extends beyond steroid metabolism to encompass broader metabolic and developmental processes.